These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27635287)

  • 1. The importance of active surveillance, and immediate re-biopsy in low-risk prostate cancer: The largest series from Turkey.
    Bayar G; Horasanlı K; Acinikli H; Tanrıverdi O; Dalkılıç A; Arısan S
    Turk J Urol; 2016 Sep; 42(3):140-4. PubMed ID: 27635287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.
    King AC; Livermore A; Laurila TA; Huang W; Jarrard DF
    Urol Oncol; 2013 Aug; 31(6):739-43. PubMed ID: 21816639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
    Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.
    Iremashvili V; Manoharan M; Lokeshwar SD; Rosenberg DL; Pan D; Soloway MS
    BJU Int; 2013 Mar; 111(3):396-403. PubMed ID: 22703025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
    Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
    BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
    Uno H; Nakano M; Ehara H; Deguchi T
    Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study.
    Naughton CK; Smith DS; Humphrey PA; Catalona WJ; Keetch DW
    Urology; 1998 Nov; 52(5):808-13. PubMed ID: 9801104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can we predict the active surveillance candidates meeting all Epstein criteria prior to prostate biopsy to avoid overdiagnosis?
    Avci S; Caglayan V
    Aging Male; 2020 Dec; 23(5):1289-1295. PubMed ID: 32406325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
    Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.
    Walton Diaz A; Shakir NA; George AK; Rais-Bahrami S; Turkbey B; Rothwax JT; Stamatakis L; Hong CW; Siddiqui MM; Okoro C; Raskolnikov D; Su D; Shih J; Han H; Parnes HL; Merino MJ; Simon RM; Wood BJ; Choyke PL; Pinto PA
    Urol Oncol; 2015 May; 33(5):202.e1-202.e7. PubMed ID: 25754621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transrectal ultrasound guided biopsy for detecting early prostate cancer: An Indian experience.
    Gupta NP; Ansari MS; Dass SC
    Indian J Cancer; 2005; 42(3):151-4. PubMed ID: 16276016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort.
    Barayan GA; Brimo F; Bégin LR; Hanley JA; Liu Z; Kassouf W; Aprikian AG; Tanguay S
    BJU Int; 2014 Dec; 114(6b):E99-E104. PubMed ID: 24684511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.
    Osterberg EC; Palmer NRA; Harris CR; Murphy GP; Blaschko SD; Chu C; Allen IE; Cooperberg MR; Carroll PR; Breyer BN
    Urol Oncol; 2017 Nov; 35(11):663.e9-663.e14. PubMed ID: 28826701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?
    Ravery V; Schmid HP; Toublanc M; Boccon-Gibod L
    Cancer; 1996 Sep; 78(5):1079-84. PubMed ID: 8780546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.